Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 1 2

Status

Recruiting 8Completed 5Terminated 3Withdrawn 2Unknown 2

Sponsor Class

OTHER 5

Study Type

Interventional 4Observational 1

Sponsor

Cancer Type

Gastrointestinal 3Gynecologic 1

Conditions

Carcinoma, Hepatocellular 3Ovarian Neoplasms 1Hepatic Malignancies 1Carcinoma, Ovarian Epithelial 1

Interventions

Cyclophosphamide 1495Cisplatin 1431Paclitaxel 1339Radiotherapy 1308Carboplatin 1264Gemcitabine 1225Docetaxel 1134Bevacizumab 1068Fluorouracil 906Doxorubicin 799Dexamethasone 753Rituximab 744Capecitabine 735Oxaliplatin 709pembrolizumab 693Etoposide 674Irinotecan 639Filgrastim 624Nivolumab 585Cytarabine 585Leucovorin 582Vincristine 512Cetuximab 478Prednisone 477Bortezomib 472Trastuzumab 469Erlotinib Hydrochloride 467Surveys and Questionnaires 460Methotrexate 443Lenalidomide 434

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × Yttrium-90 × Clear all
NCT01349075 2025-04-29

TheraSphere for the Treatment of Unresectable Hepatocellular Carcinoma

Thomas Jefferson University

Completed
474 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT00072410 2023-10-04

Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer

Ludwig Institute for Cancer Research

Phase 1 Completed
7 enrolled 7 charts
Gynecologic

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms

NCT04332419 2022-06-22

Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies

Case Comprehensive Cancer Center

Phase NA Completed
11 enrolled 7 charts

Hepatic Malignancies

NCT00846131 2016-09-15

Y-90 Alone or With Sorafenib for Pre-Transplant Hepatocellular Carcinoma

Northwestern University

Phase 1 Completed
24 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

NCT02724436 2016-03-31

Radioembolization With Yittrium-90 for Intermediate and Advanced Hepatocellular Carcinoma

Eastern Hepatobiliary Surgery Hospital

Phase NA Completed
200 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡